634.14
price down icon4.06%   -26.86
after-market アフターアワーズ: 633.16 -0.98 -0.15%
loading
前日終値:
$661.00
開ける:
$662.45
24時間の取引高:
830.53K
Relative Volume:
0.96
時価総額:
$72.26B
収益:
$14.20B
当期純損益:
$4.41B
株価収益率:
16.57
EPS:
38.28
ネットキャッシュフロー:
$3.54B
1週間 パフォーマンス:
-4.63%
1か月 パフォーマンス:
-12.35%
6か月 パフォーマンス:
-38.50%
1年 パフォーマンス:
-34.02%
1日の値動き範囲:
Value
$633.10
$662.57
1週間の範囲:
Value
$633.10
$674.83
52週間の値動き範囲:
Value
$633.10
$1,211.20

Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile

Name
名前
Regeneron Pharmaceuticals Inc
Name
セクター
Healthcare (1165)
Name
電話
(914) 847-7000
Name
住所
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
Name
職員
15,106
Name
Twitter
@regeneron
Name
次回の収益日
2025-02-04
Name
最新のSEC提出書
Name
REGN's Discussions on Twitter

REGN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.14 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
509.04 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
ARGX
Argen X Se Adr
605.52 36.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
280.96 36.37B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
250.47 27.23B 3.81B -644.79M -669.77M -6.24

Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-05 アップグレード Leerink Partners Market Perform → Outperform
2025-01-16 ダウングレード UBS Buy → Neutral
2024-12-10 再開されました BofA Securities Underperform
2024-11-15 開始されました Wolfe Research Outperform
2024-11-14 開始されました Citigroup Neutral
2024-09-24 ダウングレード Leerink Partners Outperform → Market Perform
2024-03-12 開始されました Bernstein Outperform
2024-01-12 アップグレード RBC Capital Mkts Sector Perform → Outperform
2023-11-09 開始されました Deutsche Bank Hold
2023-11-03 アップグレード Raymond James Mkt Perform → Outperform
2023-08-21 アップグレード Canaccord Genuity Hold → Buy
2023-08-21 繰り返されました Oppenheimer Perform
2023-06-28 ダウングレード Canaccord Genuity Buy → Hold
2023-03-27 アップグレード SVB Securities Market Perform → Outperform
2023-03-24 アップグレード Jefferies Hold → Buy
2023-03-23 アップグレード Raymond James Underperform → Mkt Perform
2023-01-30 アップグレード Cowen Market Perform → Outperform
2023-01-20 アップグレード JP Morgan Neutral → Overweight
2022-10-26 ダウングレード Raymond James Mkt Perform → Underperform
2022-10-17 ダウングレード Evercore ISI Outperform → In-line
2022-09-09 アップグレード Jefferies Underperform → Hold
2022-09-09 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-07-25 ダウングレード SVB Leerink Outperform → Mkt Perform
2022-07-13 開始されました Cantor Fitzgerald Neutral
2022-06-06 開始されました Jefferies Underperform
2022-05-23 開始されました SVB Leerink Outperform
2022-01-05 ダウングレード BofA Securities Neutral → Underperform
2022-01-03 アップグレード Bernstein Mkt Perform → Outperform
2021-12-15 ダウングレード Bernstein Outperform → Mkt Perform
2021-12-09 再開されました Wells Fargo Overweight
2021-12-07 再開されました Cowen Market Perform
2021-12-06 開始されました Goldman Buy
2021-11-19 再開されました BMO Capital Markets Outperform
2021-11-05 ダウングレード The Benchmark Company Buy → Hold
2021-06-29 開始されました H.C. Wainwright Buy
2021-01-25 アップグレード BMO Capital Markets Market Perform → Outperform
2021-01-13 アップグレード The Benchmark Company Hold → Buy
2021-01-08 アップグレード Citigroup Neutral → Buy
2020-10-05 アップグレード Cantor Fitzgerald Neutral → Overweight
2020-08-20 ダウングレード The Benchmark Company Buy → Hold
2020-07-09 アップグレード SunTrust Hold → Buy
2020-05-26 アップグレード Wells Fargo Equal Weight → Overweight
2020-04-28 ダウングレード Citigroup Buy → Neutral
2020-04-17 アップグレード The Benchmark Company Hold → Buy
2020-04-08 開始されました The Benchmark Company Hold
2020-03-31 開始されました Wolfe Research Peer Perform
2020-02-27 開始されました Barclays Overweight
2020-02-26 アップグレード Canaccord Genuity Hold → Buy
2020-02-26 ダウングレード Robert W. Baird Outperform → Neutral
2020-02-25 アップグレード Jefferies Hold → Buy
2020-02-11 アップグレード Argus Hold → Buy
2019-12-24 開始されました Raymond James Mkt Perform
2019-12-16 ダウングレード Evercore ISI Outperform → In-line
2019-12-13 アップグレード Credit Suisse Neutral → Outperform
2019-11-12 開始されました SunTrust Hold
2019-11-07 アップグレード Citigroup Neutral → Buy
2019-10-17 再開されました BofA/Merrill Neutral
2019-09-23 アップグレード Guggenheim Neutral → Buy
すべてを表示

Regeneron Pharmaceuticals Inc (REGN) 最新ニュース

pulisher
06:47 AM

Why Pharma and Biotech Stocks Got Thrashed on Tuesday - The Motley Fool

06:47 AM
pulisher
05:38 AM

Is Regeneron Pharmaceuticals, Inc. (REGN) a Promising Biotech Stock According to Wall Street Analysts - Yahoo Finance

05:38 AM
pulisher
04:48 AM

Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MSN

04:48 AM
pulisher
04:20 AM

Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025 - The Manila Times

04:20 AM
pulisher
01:57 AM

Regeneron stock touches 52-week low at $641.91 amid market shifts By Investing.com - Investing.com South Africa

01:57 AM
pulisher
01:57 AM

Regeneron stock touches 52-week low at $641.91 amid market shifts - Investing.com

01:57 AM
pulisher
11:19 AM

Regeneron's Franchise Tax Claims Require Trial, NY Judge Rules - Bloomberg Tax

11:19 AM
pulisher
09:55 AM

Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Extremely Profitable Stocks to Buy According to Analyst? - Insider Monkey

09:55 AM
pulisher
06:44 AM

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Corebridge Financial Inc. - MarketBeat

06:44 AM
pulisher
06:08 AM

Vanguard Group Inc. Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

06:08 AM
pulisher
12:13 PM

Lawsuit Notice: Investors who hold Regeneron - GlobeNewswire

12:13 PM
pulisher
Mar 24, 2025

11 Best Extremely Profitable Stocks to Buy According to Analysts - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

Nerve Growth Factor Market: Analysis of Epidemiology, Pipeline - openPR

Mar 24, 2025
pulisher
Mar 24, 2025

Opthea Phase 3 Trial Fails To Meet Primary Endpoint, Faces Financial Uncertainty - Benzinga

Mar 24, 2025
pulisher
Mar 24, 2025

Simplify Asset Management Inc. Lowers Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 24, 2025
pulisher
Mar 24, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Short Interest Update - MarketBeat

Mar 24, 2025
pulisher
Mar 24, 2025

KLP Kapitalforvaltning AS Makes New $34.47 Million Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 24, 2025
pulisher
Mar 24, 2025

AXQ Capital LP Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 24, 2025
pulisher
Mar 24, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Mizuho Securities USA LLC - MarketBeat

Mar 24, 2025
pulisher
Mar 24, 2025

Xponance Inc. Has $11.59 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 24, 2025
pulisher
Mar 24, 2025

DCF Advisers LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 24, 2025
pulisher
Mar 23, 2025

Harvest Fund Management Co. Ltd Buys 1,366 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

Corient Private Wealth LLC Trims Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

Forefront Wealth Management Inc. Acquires New Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

American Century Companies Inc. Sells 30,949 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

Virtu Financial LLC Has $3.06 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Summit Global Investments - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Teacher Retirement System of Texas - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

Madison Investment Advisors LLC Makes New $4.59 Million Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

Avantax Advisory Services Inc. Boosts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 23, 2025
pulisher
Mar 22, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Royal London Asset Management Ltd. - MarketBeat

Mar 22, 2025
pulisher
Mar 22, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Increased by Envestnet Portfolio Solutions Inc. - MarketBeat

Mar 22, 2025
pulisher
Mar 21, 2025

Commonwealth of Pennsylvania Public School Empls Retrmt SYS Decreases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Advisors Asset Management Inc. Sells 443 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

iA Global Asset Management Inc. Decreases Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Commonwealth Equity Services LLC Sells 967 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

11,358 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by Generali Asset Management SPA SGR - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Nikko Asset Management Americas Inc. Sells 2,730 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Genmab, NHS England, Pistoia Alliance and Regeneron Win Bio-IT World Innovative Practices Awards - PR Newswire

Mar 21, 2025
pulisher
Mar 21, 2025

First Week of November 21st Options Trading For Regeneron Pharmaceuticals (REGN) - Nasdaq

Mar 21, 2025
pulisher
Mar 21, 2025

Blueshift Asset Management LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Vinva Investment Management Ltd Buys 1,182 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

3 Reasons to Sell REGN and 1 Stock to Buy Instead - Financial Content

Mar 21, 2025
pulisher
Mar 21, 2025

Short Interest in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Increases By 16.8% - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Cibc World Markets Corp Grows Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Age-Related Macular Degeneration Therapeutics Market - openPR

Mar 21, 2025
pulisher
Mar 20, 2025

Natixis Advisors LLC Decreases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 20, 2025
pulisher
Mar 20, 2025

Kazazian Asset Management LLC Invests $399,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 20, 2025
pulisher
Mar 20, 2025

Thrivent Financial for Lutherans Has $89.18 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 20, 2025
pulisher
Mar 20, 2025

Intact Investment Management Inc. Acquires Shares of 500 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 20, 2025

Regeneron Pharmaceuticals Inc (REGN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$605.52
price down icon 0.40%
$280.96
price down icon 3.35%
biotechnology ONC
$250.47
price down icon 1.08%
$97.05
price down icon 3.57%
$20.24
price down icon 2.17%
大文字化:     |  ボリューム (24 時間):